James F Casella MD
Professor of Pediatrics, Professor of Oncology, Johns Hopkins University School of Medicine; Chief of Pediatric Hematology
Join to View Full Profile
200 North Wolfe StreetRubenstein BLDG Lower LevelBaltimore, MD 21287
Phone+1 443-997-5437
Fax+1 410-367-2748
Dr. Casella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1979 - 1983- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1979 - 1980
- Johns Hopkins UniversityResidency, Pediatrics, 1976 - 1979
SUNY Upstate Medical UniversityClass of 1976
Certifications & Licensure
MD State Medical License 1980 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia Start of enrollment: 2000 Aug 01
- Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Start of enrollment: 2012 Aug 16
Publications & Presentations
PubMed
- FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestries.Ambroise Wonkam, Kevin Esoh, Rachel M Levine, Valentina Josiane Ngo Bitoungui, Khuthala Mnika
Nature Communications. 2025-03-01 - Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcom...Neil A Goldenberg, Sam Schulman, John M Kittelson, Thomas C Abshire, James F Casella
Journal of Thrombosis and Haemostasis. 2025-02-01 - 2 citationsHydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.James F Casella, Dana K Furstenau, Robert J Adams, Donald J Brambilla, Jeffrey D Lebensburger
American Journal of Hematology. 2024-10-01
Abstracts/Posters
- Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell DiseaseJames F. Casella, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Neurodevelopmental Disorders in Pediatric Sickle Cell DiseaseJames F. Casella, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- New Drugs Regrows Hair in 40% of PatientsMay 26th, 2022
- Poloxamer 188 Disappoints for Painful SCD Vaso-Occlusive Episodes, Study ShowsteaserMay 27th, 2021
Poloxamer 188 Disappoints for Painful SCD Vaso-Occlusive Episodes, Study ShowsteaserMay 27th, 2021- Join now to see all
Grant Support
- Clinical Hematology Research Career Development Program (K12) At HopkinsNational Heart, Lung, And Blood Institute2012
- Hydroxyurea To Prevent CNS Complications Of Sickle Cell Disease In ChildrenNational Heart, Lung, And Blood Institute2011
- Comprehensive Sickle Cell Center At Jhu And UABNational Heart, Lung, And Blood Institute2009–2011
- Sickle Cell Scholar ComponentNational Heart, Lung, And Blood Institute2008–2011
- Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery And Validation In SCINational Heart, Lung, And Blood Institute2008–2011
- Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
- Clinical Hematology Research Development Program (K12) At Johns HopkinsNational Heart, Lung, And Blood Institute2006–2010
- Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2008
- Silent Cerebral Infarct Multi-Center Clinical TrialNational Center For Research Resources2006–2007
- Baby HUGNational Center For Research Resources2005–2007
- Stroke Prevention Trial In Sickle Cell Anemia (Stop Ii)National Center For Research Resources2004–2005
- Cognitive And Neuroimaging Studies Of Children With Sickle Cell DiseaseNational Center For Research Resources2004
- Cognitive And Neuroimaging In Studies Of Children WithNational Center For Research Resources2004
- Flocor In Patients With Sickle Cell Disease CrisisNational Center For Research Resources2000–2002
- Phase III Multicntr,Db,Placebo Cont Study Of CRL 5861 In Sickle Cell AnemiaNational Center For Research Resources1999–2002
- Pediatric Hydroxyuera Phase III Clinical TrialDivision Of Blood Diseases And Resources2000
- Molecular Analysis Of A Muscle Actin-Capping ProteinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992–1996
- Actin-Capping Protein Interactions In MuscleNational Heart, Lung, And Blood Institute1987–1991
- Actin Capping Proteins In Platelets And MuscleNational Heart, Lung, And Blood Institute1985–1988
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/james-casella
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
